🚀 VC round data is live in beta, check it out!
Airway Medix Valuation Multiples
Discover revenue and EBITDA valuation multiples for Airway Medix and similar public comparables like Cuprina Holdings (Cayman), BioRegenx, Etropal, Ortivus and more.
Airway Medix Overview
About Airway Medix
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
Founded
2013
HQ
Employees
632
Website
Sectors
Financials (FY)
EV
$13M
Airway Medix Financials
Airway Medix reported last fiscal year revenue of $3K and negative EBITDA of ($3M).
In the same fiscal year, Airway Medix generated ($2K) in gross profit, ($3M) in EBITDA losses, and had net loss of ($3M).
Airway Medix P&L
In the most recent fiscal year, Airway Medix reported revenue of $3K and EBITDA of ($3M).
Airway Medix expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($2K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (50%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($3M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (91042%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (42150%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($3M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (97792%) | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Airway Medix Stock Performance
Airway Medix has current market cap of $9M, and enterprise value of $13M.
Market Cap Evolution
Airway Medix's stock price is $0.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $9M | 0.7% | XXX | XXX | XXX | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAirway Medix Valuation Multiples
Airway Medix trades at 3877.5x EV/Revenue multiple, and (4.3x) EV/EBITDA.
Airway Medix Financial Valuation Multiples
As of April 11, 2026, Airway Medix has market cap of $9M and EV of $13M.
Equity research analysts estimate Airway Medix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Airway Medix has a P/E ratio of (2.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3877.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (9.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (7754.9x) | XXX | XXX | XXX |
| P/E | — | XXX | (2.8x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (6.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Airway Medix Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Airway Medix Margins & Growth Rates
Airway Medix's revenue in the last fiscal year grew by 0%.
Airway Medix's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Airway Medix Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (91042%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 788% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 42100% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Airway Medix Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cuprina Holdings (Cayman) | XXX | XXX | XXX | XXX | XXX | XXX |
| BioRegenx | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Ortivus | XXX | XXX | XXX | XXX | XXX | XXX |
| Momina Krepost | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Airway Medix M&A Activity
Airway Medix acquired XXX companies to date.
Last acquisition by Airway Medix was on XXXXXXXX, XXXXX. Airway Medix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Airway Medix
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAirway Medix Investment Activity
Airway Medix invested in XXX companies to date.
Airway Medix made its latest investment on XXXXXXXX, XXXXX. Airway Medix invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Airway Medix
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Airway Medix
| When was Airway Medix founded? | Airway Medix was founded in 2013. |
| Where is Airway Medix headquartered? | Airway Medix is headquartered in Poland. |
| How many employees does Airway Medix have? | As of today, Airway Medix has over 632 employees. |
| Is Airway Medix publicly listed? | Yes, Airway Medix is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Airway Medix? | Airway Medix trades under AWM ticker. |
| When did Airway Medix go public? | Airway Medix went public in 2014. |
| Who are competitors of Airway Medix? | Airway Medix main competitors are Cuprina Holdings (Cayman), BioRegenx, Etropal, Ortivus. |
| What is the current market cap of Airway Medix? | Airway Medix's current market cap is $9M. |
| What is the current revenue of Airway Medix? | Airway Medix's last fiscal year revenue is $3K. |
| What is the current EV/Revenue multiple of Airway Medix? | Current revenue multiple of Airway Medix is 3877.5x. |
| Is Airway Medix profitable? | No, Airway Medix is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.